Andrew Guggenhime, President and CFO at Vaxcyte, Inc. (PCVX), sold 15,883 shares at $60.17 ($956K) on 2023-12-18, disclosed to the SEC on 2023-12-20.
Scheduled sale ($956k) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.17 | 7,883 | $474K | 49.6% |
| 2 | $60.17 | 7,883 | $474K | 49.6% |
| 3 | $60.79 | 117 | $7K | 0.7% |
| Total | $60.17 avg | 15,883 | $956K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |